SCHEMBL16480968

SCHEMBL16480968

CCOC(=O)CCc1ccc(-c2ccc(C(=O)OCC)cc2)n1-c1ccc(C(N)=O)cc1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 1/20 0.56
CYP2C19 P33261 1/20 0.56
MAPT P10636 7/20 0.52
POLB P06746 5/20 0.52
MYC P01106 1/20 0.42
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
PKM P14618 1/20 0.42
TP53 P04637 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAOA P21397 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12556796 0.93 ADH5 (0.55) ADH5CYP2C19MAPTPOLBMYC
SCHEMBL16480967 0.92 ADH5 (0.66) ADH5CYP2C19MAPTPOLBMYC
SCHEMBL1847134 0.92 ADH5 (0.56) ADH5CYP2C19MAPTPOLBMYC
SCHEMBL1835007 0.92 ADH5 (0.56) ADH5CYP2C19MAPTPOLBMYC
SCHEMBL1826262 0.91 ADH5 (0.55) ADH5CYP2C19MAPTPOLBMYC
SCHEMBL1826552 0.91 ADH5 (0.55) ADH5CYP2C19MAPTPOLBMYC
SCHEMBL1826897 0.90 ADH5 (0.54) ADH5CYP2C19MAPTPOLBKDM4E
SCHEMBL13494875 0.89 ADH5 (0.56) ADH5CYP2C19MAPTPOLBMYC
SCHEMBL1974832 0.89 ADH5 (0.53) ADH5CYP2C19MAPTPOLBMYC
SCHEMBL1834947 0.89 ADH5 (0.55) ADH5CYP2C19MAPTPOLBMYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318006-B1 NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS NIVALIS THERAPEUTICS INC (US) 2016-10-12 EP disclosed
US-9138427-B2 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents NIVALIS THERAPEUTICS, INC. (US) 2015-09-22 US disclosed
US-8691816-B2 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents N30 PHARMACEUTICALS, INC. (US) 2014-04-08 US disclosed